DNAtriX's Series B Round

DNAtriX raised a round of funding on October 14, 2014.

DNAtrix is developing modified viruses for the treatment of the most aggressive forms of cancer. Since viruses are already efficient at killing cells, scientists have harnessed this ability by modifyi…

Articles about DNAtriX's Series B Round: